PURPOSE: To investigate whether the Patient Health Questionnaire-9 (PHQ-9) possesses the essential psychometric characteristics to measure depressive symptoms in people with visual impairment. METHODS: The PHQ-9 scale was completed by 103 participants with low vision. These data were then assessed for fit to the Rasch model. RESULTS: The participants' mean +/- standard deviation (SD) age was 74.7 +/- 12.2 years. Almost one half of them (n = 46; 44.7%) were considered to have severe vision impairment (presenting visual acuity <6/60 in the better eye). Disordered thresholds were evident initially. Collapsing the two middle categories produced ordered thresholds and fit to the Rasch model (chi = 10.1; degrees of freedom = 9; p = 0.34). The mean (SD) items and persons Fit Residual values were -0.31 (1.12) and -0.25 (0.78), respectively, where optimal fit of data to the Rasch model would have a mean = 0 and SD = 1. Unidimensionality was demonstrated confirming the construct validity of the PHQ-9 and there was no evidence of differential item functioning on a number of factors including visual disability. The person separation reliability value was 0.80 indicating that the PHQ-9 has satisfactory precision. There was a degree of mistargeting as expected in this largely non-clinically depressed sample. CONCLUSIONS: Our findings demonstrate that the PHQ-9, when scaled with Rasch analysis, forms a linear interval measurement of depressive symptoms suitable for use in a vision impaired population.
PURPOSE: To investigate whether the Patient Health Questionnaire-9 (PHQ-9) possesses the essential psychometric characteristics to measure depressive symptoms in people with visual impairment. METHODS: The PHQ-9 scale was completed by 103 participants with low vision. These data were then assessed for fit to the Rasch model. RESULTS: The participants' mean +/- standard deviation (SD) age was 74.7 +/- 12.2 years. Almost one half of them (n = 46; 44.7%) were considered to have severe vision impairment (presenting visual acuity <6/60 in the better eye). Disordered thresholds were evident initially. Collapsing the two middle categories produced ordered thresholds and fit to the Rasch model (chi = 10.1; degrees of freedom = 9; p = 0.34). The mean (SD) items and persons Fit Residual values were -0.31 (1.12) and -0.25 (0.78), respectively, where optimal fit of data to the Rasch model would have a mean = 0 and SD = 1. Unidimensionality was demonstrated confirming the construct validity of the PHQ-9 and there was no evidence of differential item functioning on a number of factors including visual disability. The person separation reliability value was 0.80 indicating that the PHQ-9 has satisfactory precision. There was a degree of mistargeting as expected in this largely non-clinically depressed sample. CONCLUSIONS: Our findings demonstrate that the PHQ-9, when scaled with Rasch analysis, forms a linear interval measurement of depressive symptoms suitable for use in a vision impaired population.
Authors: Rebecca M Saracino; Ezgi Aytürk; Heining Cham; Barry Rosenfeld; Leah M Feuerstahler; Christian J Nelson Journal: Psychol Assess Date: 2019-08-08
Authors: Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Natasha Riley; Georgia Robins Sadler Journal: Cultur Divers Ethnic Minor Psychol Date: 2011-07
Authors: P K Crane; L E Gibbons; J H Willig; M J Mugavero; S T Lawrence; J E Schumacher; M S Saag; M M Kitahata; H M Crane Journal: AIDS Care Date: 2010-07
Authors: Xinzhi Zhang; Kai McKeever Bullard; Mary Frances Cotch; M Roy Wilson; Barry W Rovner; Gerald McGwin; Cynthia Owsley; Lawrence Barker; John E Crews; Jinan B Saaddine Journal: JAMA Ophthalmol Date: 2013-05 Impact factor: 7.389
Authors: Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; Allen C Ho; William S Tasman Journal: Ophthalmology Date: 2014-07-09 Impact factor: 12.079
Authors: Gabrielle D Lacy; Maria Fernanda Abalem; Chris A Andrews; Rebhi Abuzaitoun; Lilia T Popova; Erin P Santos; Gina Yu; Hanan Y Rakine; Natasha Baig; Joshua R Ehrlich; Abigail T Fahim; Kari H Branham; Bonnielin K Swenor; Paul R Lichter; Gislin Dagnelie; Joan A Stelmack; David C Musch; K Thiran Jayasundera Journal: Am J Ophthalmol Date: 2020-12-09 Impact factor: 5.258
Authors: Hilde Pa van der Aa; Ger Hmb van Rens; Frank D Verbraak; Machteld Bosscha; Hannie C Comijs; Ruth Ma van Nispen Journal: Ophthalmic Physiol Opt Date: 2021-05-29 Impact factor: 3.117